ALZINT

Alzheimer International Society is a non-profit organization with the mission to find a treatment for Alzheimer’s disease.

[ALZINT @ALZINT1]

Lecanemab is Neither Safe nor Effective in Treating Alzheimer’s Patients-
according to the Alzheimer International Society’s scientific panel

https://t.co/Y2nZ1JEWq0 via @ein_news

[ALZINT @ALZINT1]

The ASIC 2023 will feature a broad range of topics including:
* Amyloid Hypothesis and Alternative Hypotheses

* Open Forum on Medicare's decision on Aducanumab and Lecanemab:

*A Public Debate on Research Directions for Alzheimer's Disease

https://t.co/NnbjVn1J22

[ALZINT @ALZINT1]

The Alzheimer Society International Congress (ASIC) September 12-14, 2023 in San Francisco.
Main theme:“The Next Frontier Against Alzheimer's”.

https://t.co/TJ2kqJpnPc

[ALZINT @ALZINT1]

Impact: COVID-19 <--> ALZHEIMER'S?
-Join Zoom videoconf discussion Sat. Jun 27, 10am PT (free)
-RSVP: https://t.co/HIGxIrJteR

[ALZINT @ALZINT1]

ALZINT wishes success to The 8th Annual Neurodegenerative Drug Development Summit, February 25-27, 2020 in Boston.

--> Only 11 passes remaining! <---

https://t.co/VavlYibeV4

[ALZINT @ALZINT1]

The 8th Annual Neurodegenerative Drug Development Summit, February 25-27, 2020 in Boston.
Special discount for members of the Alzheimer International Society, use the discount code: "AIS20" to get 20% off the registration fees.
For more information: https://t.co/VavlYibeV4

[ALZINT @ALZINT1]

The 8th Annual Neurodegenerative Drug Development Summit, February 25-27, 2020 in Boston. Special discount for members of the Alzheimer International Society, use the discount code: "AIS20" to get 20% off the registration fees.
For more information: https://t.co/bDB1FGllq0

[ALZINT @ALZINT1]

Expert Opinion Survey: Aducanumab

AIS is conducting a poll from subject experts about the clinical data of Aducanumab. The updated results of Aducanumab were published by Biogen in the public domain: https://t.co/GsBhwDb3RN
Your expert opinion is welcome: https://t.co/1lhN9IGMrx

[ALZINT @ALZINT1]

ASIC 2020
Alzheimer Society International Congress, June 16-18, 2020 in San Francisco.
ASIC 2020 is a leading forum in Alzheimer research and dementia care.
https://t.co/757Cfn50Go
Submit an abstract: https://t.co/k7ez0GCtCw

[ALZINT @ALZINT1]

UPDATED: Merck makes a $773M bet on TGFβ, acquiring a three-year-old biotech - https://t.co/umIOfVfGyt

[ALZINT @ALZINT1]

New Study Explains Why So Many Alzheimer's Clinical Trials Failed https://t.co/38GnuK9A98

[ALZINT @ALZINT1]

Clinical Trials in Alzheimer's Disease Are Failing: What Can Be Done? https://t.co/IjmSGgGuSI

[ALZINT @ALZINT1]

ASIC 2019: preliminary schedule has been posted online:
https://t.co/D9AqjDvhbl

[ALZINT @ALZINT1]

If Dr. Alois Alzheimer was alive today, he could not offer any better treatment than what he knew in the beginning of last century, which was none.
Over the past 112 years all the research efforts have failed to develop a drug for prevent or treatment of Alzheimer’s disease.

[ALZINT @ALZINT1]

Roche Alzheimer’s drug suffers trial failure:
https://t.co/INzqEKdLtV

[ALZINT @ALZINT1]

ASIC 2019 will present a panel discussion on Tuesday February 19 at 8:45 AM - 10:15 AM on “After 40 year of research failure in Alzheimer’s- Where are we headed?”
https://t.co/D9AqjDvhbl

[ALZINT @ALZINT1]

ALZINT is the organizer of the Alzheimer Society International Congress, February 18-21, 2019 at San Francisco Airport Crowne Plaza.
https://t.co/NnbjVniM42